PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Lucknow, India.\', \'Nanomedicine Unit, College of Medicine and Medical Sciences, Al-Jawhara Center for Molecular Medicine and Inherited Disorders, Arabian Gulf University, Manama, Bahrain.\', \'Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/1061186X.2021.2013852
?:hasPublicationType
?:journal
  • Journal of drug targeting
is ?:pmid of
?:pmid
?:pmid
  • 34854327
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.851
?:rankingScore_hIndex
  • 77
?:title
  • Drug repurposing strategies and key challenges for COVID-19 management.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34854327>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34854327>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all